Ahmet Dogan

age ~65

from New York, NY

Get Report

Also known as:

Amhet Dogan

Phone and address:: 345 E 68Th St APT 4D, New York, NY 10065

Connected to:

Ahmet Dogan Phones & Addresses

345 E 68Th St APT 4D, New York, NY 10065
East Hampton, NY
Sag Harbor, NY
806 8Th St, Rochester, MN 55902 • (507)5290762
3418 Wright Rd, Rochester, MN 55902 • (507)2084036

Work

Company:

Mayo Clinic
Address:

200 1St St Sw, Rochester, MN 55905
Phones:

(507)2842511

Languages

English

Industries

Medical Practice

Specialities

Clinical Pathology

Isbn (Books And Publications)

Pathology Integrated: An A-Z of Disease and Its Pathogenesis

view source

Author
Ahmet Dogan

ISBN #
0340740639

Basic Pathology: An Introduction to the Mechanisms of Disease

view source

Author
Ahmet Dogan

ISBN #
0340810017

Resumes

Ahmet Dogan

view source

Location:

New York, NY

Industry:

Medical Practice

Work:

Memorial Sloan Kettering Cancer Center
Chief, Hematopathology Service

Medicine Doctors

Dr. Ahmet Dogan, Rochester MN - MD (Doctor of Medicine)

view source

Specialties:

Clinical Pathology

Address:

Mayo Clinic
200 1St St Sw, Rochester, MN 55905
(507)2842511 (Phone)

Languages:

English

Hospitals:

Mayo Clinic
200 1St St Sw, Rochester, MN 55905

Mayo Clinic Saint Marys Hospital
1216 2Nd Street South West, Rochester, MN 55902

North Memorial Medical Center
3300 Oakdale Avenue North, Robbinsdale, MN 55422

Ahmet Dogan

view source

Specialties:

Nuclear Medicine
Clinical Pathology/Laboratory Medicine

Education:

Hacettepe Universitesi (1984)

Ahmet Dogan, Rochester MN

view source

Specialties:

Pathologist

Address:

200 1St St Sw, Rochester, MN 55905
1275 York Ave, New York, NY 10065

Us Patents

Reducing Irf4, Dusp22, Or Flj43663 Polypeptide Expression
view source
US Patent:

20100324119, Dec 23, 2010
Filed:

May 18, 2010
Appl. No.:

12/782484
Inventors:

Andrew L. Feldman - Rochester MN, US
Ahmet Dogan - Rochester MN, US
George Vasmatzis - Oronoco MN, US
Mark Law - Rochester MN, US
David I. Smith - Rochester MN, US
Assignee:

MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH - Rochester MN
International Classification:

A61K 31/713
C12Q 1/68
G01N 33/68
A61P 35/00
US Classification:

514 44 A, 435 6, 435 71
Abstract:

This document relates to the activity of interferon regulatory factor 4 (IRF4) in T-cell lymphomas. For example, methods and materials involved in reducing the expression of an IRF4 polypeptide in T-cell lymphoma cells and identifying agents having the ability to reduce expression of an IRF4 polypeptide in T-cell lymphoma cells are provided. This document also relates to reducing DUSP22 or FLJ43663 polypeptide activity in T-cell lymphomas. For example, methods and materials involved in reducing the expression of DUSP22 polypeptides and/or FLJ43663 polypeptides in T-cell lymphoma cells and identifying agents having the ability to reduce expression of DUSP22 polypeptides and/or FLJ43663 polypeptides in T-cell lymphoma cells are provided.

Reducing Irf4, Dusp22, Or Flj43663 Polypeptide Expression
view source
US Patent:

20110306517, Dec 15, 2011
Filed:

Aug 19, 2011
Appl. No.:

13/213390
Inventors:

Andrew L. Feldman - Rochester MN, US
Ahmet Dogan - Rochester MN, US
George Vasmatzis - Oronoco MN, US
Mark Law - Rochester MN, US
David I. Smith - Rochester MN, US
Assignee:

MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH - Rochester MN
International Classification:

C40B 30/04
C12Q 1/42
G01N 33/573
C12Q 1/68
US Classification:

506 9, 435 618, 435 21, 435 71
Abstract:

This document relates to the activity of interferon regulatory factor 4 (IRF4) in T-cell lymphomas. For example, methods and materials involved in reducing the expression of an IRF4 polypeptide in T-cell lymphoma cells and identifying agents having the ability to reduce expression of an IRF4 polypeptide in T-cell lymphoma cells are provided. This document also relates to reducing DUSP22 or FLJ43663 polypeptide activity in T-cell lymphomas. For example, methods and materials involved in reducing the expression of DUSP22 polypeptides and/or FLJ43663 polypeptides in T-cell lymphoma cells and identifying agents having the ability to reduce expression of DUSP22 polypeptides and/or FLJ43663 polypeptides in T-cell lymphoma cells are provided.

Classifying Amyloidosis
view source
US Patent:

20100323381, Dec 23, 2010
Filed:

Feb 6, 2009
Appl. No.:

12/866709
Inventors:

Steven R. Zeldenrust - Rochester MN, US
David R. Barnidge - Rochester MN, US
Ahmet Dogan - Rochester MN, US
Julie A. Vrana - Rochester MN, US
Jeffrey D. Gamez - Rochester MN, US
Jason D. Theis - Kasson MN, US
International Classification:

C12Q 1/37
US Classification:

435 23
Abstract:

This document provides methods and materials related to determining the identity of amyloid polypeptides in biological samples. For examples, methods and materials for identifying an amyloid polypeptide present in a fat aspirate are provided herein.